Author: Lior Ishai

Home / Articles posted by Lior Ishai (Page 2)

BERLIN, Germany, September 6, 2019 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX), (FSE: C4T, ISIN: CA00176G1028) announces that it has granted incentive stock options to purchase up to 2,120,000 common shares of the Company to certain directors, officers, employees and consultants in accordance with its stock option plan, including options to purchase up to 1,175,000 shares to certain directors and officers. Each option vests immediately has an exercise price of $0.50 per share and is exercisable...

BERLIN, Germany, August 22, 2019 – Chinook Tyee Industry Limited ("Chinook" or the "Company") (TSXV: XCX), (Frankfurt: C4T: ISIN: CA16961T2083) announces that the Canadian Securities Exchange ("CSE") has approved the listing of the Company's Class A Voting Common Shares Without Par Value ("Common Shares") and will begin trading at market open on September 4, 2019 under the Company's current symbol, "XCX" ("CSE Listing").  The Company also announces that it has changed its name to "AMP German Cannabis Group Inc." and its...

Chinook Insiders are the largest investors in the Series A financing as its German subsidiary expands in the European medical cannabis industry BERLIN, Germany, June 12th, 2019 – Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX), (Frankfurt: C4T, ISIN: CA16961T2083) completed its Series A non-brokered placement (Private Placement) of 10,000,000 Common Shares at a subscription price of $0.15 per Common Share (Common Shares), raising $1,500,000, which Chinook intends to use for working capital purposes. All securities issued pursuant to the Private Placement will be subject to a...

Chinook establishes EU-GMP standards for its imports of medical cannabis to Germany from Canada   BERLIN, Germany, May 29, 2019 /CNW/ - Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX), (Frankfurt: C4T, ISIN: CA16961T2083) has entered into a consulting agreement with a leading German pharmaceutical and medical consulting company, pursuant to which, among other things, the consultant shall evaluate and confirm that medical cannabis produced by a Canadian licensed producer of cannabis (a "LP") that has entered into a supply agreement with Chinook meets EU-GMP regulations for importing medical cannabis into Germany from...

BERLIN, Germany, May 8th, 2019 – Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) (FSE: C4T), has granted incentive stock options to purchase up to 1,020,000 common shares of Chinook to its directors, officers, employees, and consultants in Germany, Switzerland and Canada pursuant to its stock option plan, including 655,000 options issued to directors and officers. Each option vests immediately, has an exercise price of $0.15 per share and is valid for a period of one year from the date of issuance.   Chinook Tyee Industry Limited Chinook is...

BERLIN, Germany, May 6th, 2019 – Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) (FSE: C4T), announces a non-brokered placement of up to 10,000,000 common shares at a price of $0.15 per share for gross proceeds of up to $1.5-million for working capital purposes. All securities issued pursuant to the offering will be subject to a statutory hold period of four months plus a day from issuance in accordance with applicable securities laws. Chinook expects to complete...

BERLIN, DEUTSCHLAND, 3. Mai 2019 | Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX), (FSE: C4T) kündigt an, dass eigene, stimmberechtigte Stammaktien an der Frankfurter Börse (FSE) unter dem Handelszeichen "C4T" (WKN: A12DYZ, ISIN: CA16961T2083) gehandelt werden können. Im Rahmen der Marktpflege repräsentiert die Baader Bank AG Chinook in Deutschland. “Europa wird absehbar innerhalb der kommenden fünf Jahre der größte Markt für legales Cannabis werden, da in Europa mehr als 740 Millionen Menschen beheimatet sind und hier die Bevölkerung mehr als doppelt...

BERLIN, GERMANY, May 3rd, 2019 | Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX), (FSE: C4T) is pleased to announce that its Class A Voting Common Shares will be listed for trading on the Frankfurt Stock Exchange (FSE), also known as Börse Frankfurt, under the trading symbol "C4T" (WKN: A12DYZ, ISIN: CA16961T2083). The market maker representing Chinook in Germany is Baader Bank AG. "Europe is set to become the world's largest legal cannabis market over the next five years as it is home to more than 740...

ERFURT, Germany and EDMONTON, Feb. 7, 2019 /CNW/ - AMP Alternative Medical Products GmbH ("AMP"), a subsidiary of Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX), has entered into a non-binding Memorandum of Understanding Production Supply Agreement ("MOU") with Pure Life Cannabis Corporation ("PLCC"), a late-stage Health Canada applicant to become a licensed producer of cannabis ("LP") based in Edmonton, Alberta. PLCC is in the process of building a 27,280 square foot Phase 1 facility, which it anticipates can produce approximately 2,000 kilograms of EU-GMP cannabis flower annually and...

BERLIN, Feb. 5, 2019 /CNW/ - Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) is an investment finance company with two European subsidiaries, AMP Alternative Medical Products GmbH based in Erfurt, Germany and Mercury Partners & Company plc based in Valletta, Malta. Chinook has 10,217,796 fully diluted shares issued and outstanding and net investment assets of over $2.0 million (unaudited) as of September 30th, 2018. About AMP Alternative Medical Products ("AMP")AMP Alternative Medical Products GmbH, is a biopharmaceutical company based in the German state of Thuringia and provides medical cannabis formulations and...